• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旅行者中的多克隆恶性疟原虫疟疾及氯胍预防后抗叶酸突变的选择

Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis.

作者信息

Färnert Anna, Tengstam Karolin, Palme Ingela Berggren, Bronner Ulf, Lebbad Marianne, Swedberg Göte, Björkman Anders

机构信息

Department of Medicine, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden.

出版信息

Am J Trop Med Hyg. 2002 May;66(5):487-91. doi: 10.4269/ajtmh.2002.66.487.

DOI:10.4269/ajtmh.2002.66.487
PMID:12201581
Abstract

The polymorphism of malaria parasites will greatly influence the efficiency of antimalarial drugs and vaccines. This study determined the genetic diversity of Plasmodium falciparum infections in 107 travelers and estimated the importance of mutations in the parasite dihydrofolate reductase (dhfr) gene for clinical breakthrough during proguanil prophylaxis. Genotyping with regards to the three highly polymorphic antigen-coding regions (merozoite surface protein-1 [msp-1], msp-2, and the glutamate-rich protein [glurp]) revealed multiple genotypes (up to five) in 64% of the patients. Single genotype infections were mainly associated with prior intake of antimalarial drugs, but also with a shorter stay in a malaria-endemic area and low parasite density. Malaria breakthrough despite proguanil prophylaxis was always associated with mutations in the dhfr gene; always the Asn-108 mutation and often the Ile-51 and Arg-59 mutations. The Leu-164 mutation was found in four travelers from Africa. Travelers with limited time in an endemic area were often infected with polyclonal P. falciparum infections, which suggests that single mosquito inoculations are often composed of several genetically diverse parasites. Chemoprophylaxis reduces the number of infecting clones and selects for resistant parasites as shown for proguanil through mutations in the dhfr gene.

摘要

疟原虫的多态性会极大地影响抗疟药物和疫苗的效力。本研究确定了107名旅行者中恶性疟原虫感染的遗传多样性,并评估了寄生虫二氢叶酸还原酶(dhfr)基因中的突变对于氯胍预防期间临床突破的重要性。针对三个高度多态的抗原编码区域(裂殖子表面蛋白-1 [msp-1]、msp-2和富含谷氨酸的蛋白 [glurp])进行基因分型,结果显示64%的患者存在多种基因型(多达五种)。单一基因型感染主要与先前服用抗疟药物有关,但也与在疟疾流行地区停留时间较短以及寄生虫密度较低有关。尽管进行了氯胍预防仍出现疟疾突破,这总是与dhfr基因中的突变有关;总是出现Asn-108突变,并且常常出现Ile-51和Arg-59突变。在来自非洲的四名旅行者中发现了Leu-164突变。在流行地区停留时间有限的旅行者常常感染多克隆恶性疟原虫,这表明单次蚊虫叮咬通常由几种基因不同的寄生虫组成。化学预防减少了感染克隆的数量,并如氯胍通过dhfr基因中的突变所显示的那样,选择出耐药寄生虫。

相似文献

1
Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis.旅行者中的多克隆恶性疟原虫疟疾及氯胍预防后抗叶酸突变的选择
Am J Trop Med Hyg. 2002 May;66(5):487-91. doi: 10.4269/ajtmh.2002.66.487.
2
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.恶性疟原虫细胞色素b基因的突变与接受阿托伐醌-氯胍治疗的疟疾患者中寄生虫复发延迟有关。
Malar J. 2008 Nov 20;7:240. doi: 10.1186/1475-2875-7-240.
3
Plasmodium falciparum: pfcrt and DHFR mutations are associated with failure of chloroquine plus proguanil prophylaxis in travelers.恶性疟原虫:pfcrt和二氢叶酸还原酶突变与旅行者中氯喹加氯胍预防治疗失败相关。
J Infect Dis. 2001 Dec 15;184(12):1633-4. doi: 10.1086/324616.
4
Proguanil resistance in Plasmodium falciparum African isolates: assessment by mutation-specific polymerase chain reaction and in vitro susceptibility testing.恶性疟原虫非洲分离株对氯胍的耐药性:通过突变特异性聚合酶链反应和体外药敏试验进行评估
Am J Trop Med Hyg. 1997 Dec;57(6):646-50. doi: 10.4269/ajtmh.1997.57.646.
5
Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.氯胍对恶性疟和间日疟的内在疗效与代谢产物环氯胍无关。
J Infect Dis. 1999 Apr;179(4):974-9. doi: 10.1086/314683.
6
Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.喀麦隆雅温得疟疾的分子流行病学。VI. 恶性疟原虫二氢叶酸还原酶-胸苷酸合成酶基因的序列变异及对乙胺嘧啶和环氯胍的体外抗性
Am J Trop Med Hyg. 2000 Feb;62(2):271-6. doi: 10.4269/ajtmh.2000.62.271.
7
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.智利输入性疟疾病例中阿托伐醌/伯氨喹耐药性。
Am J Trop Med Hyg. 2021 Mar 29;104(5):1811-1813. doi: 10.4269/ajtmh.20-1095.
8
Mutations in dhfr in Plasmodium falciparum infections selected by chlorproguanil-dapsone treatment.氯胍-氨苯砜治疗所选择的恶性疟原虫感染中dhfr的突变
J Infect Dis. 2002 Dec 15;186(12):1861-4. doi: 10.1086/345765. Epub 2002 Nov 15.
9
Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria.尼日利亚接受氯喹治疗的儿童恶性疟原虫复发性疟疾感染的分子分析
Am J Trop Med Hyg. 2004 Jan;70(1):20-6.
10
Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.在来自非洲的未接触过阿托伐醌-氯胍的恶性疟原虫分离株中,与阿托伐醌-氯胍耐药性相关的突变出现的确认。
Malar J. 2006 Oct 4;5:82. doi: 10.1186/1475-2875-5-82.

引用本文的文献

1
Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.疟疾盒化合物抗疟原虫临床分离株的抗疟活性。
Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):399-406. doi: 10.1016/j.ijpddr.2017.10.005. Epub 2017 Oct 16.
2
Plasmodium falciparum genotype diversity in artemisinin derivatives treatment failure patients along the Thai-Myanmar border.泰国-缅甸边境青蒿素衍生物治疗失败患者中恶性疟原虫的基因型多样性
Korean J Parasitol. 2014 Dec;52(6):631-7. doi: 10.3347/kjp.2014.52.6.631. Epub 2014 Dec 23.
3
Drug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patients.
直接从疟疾患者外周血中进行全基因组测序分析恶性疟原虫的耐药基因型和多克隆性。
PLoS One. 2011;6(8):e23204. doi: 10.1371/journal.pone.0023204. Epub 2011 Aug 11.
4
Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.卢旺达儿童恶性疟原虫感染中高水平抗叶酸耐药的分子相关性。
Antimicrob Agents Chemother. 2010 Jan;54(1):477-83. doi: 10.1128/AAC.00498-09. Epub 2009 Oct 19.
5
Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.肯尼亚西部亚显微配子体与耐抗叶酸恶性疟原虫的传播
PLoS One. 2009;4(2):e4364. doi: 10.1371/journal.pone.0004364. Epub 2009 Feb 5.
6
Detection of the dihydrofolate reductase-164L mutation in Plasmodium falciparum infections from Malawi by heteroduplex tracking assay.通过异源双链追踪分析法检测马拉维恶性疟原虫感染中的二氢叶酸还原酶-164L突变。
Am J Trop Med Hyg. 2008 Jun;78(6):892-4.
7
Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections.采用异源双链追踪分析法评估复杂恶性疟原虫感染患者的真正抗疟疗效。
Antimicrob Agents Chemother. 2007 Feb;51(2):521-7. doi: 10.1128/AAC.00902-06. Epub 2006 Nov 20.
8
Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.马拉维布兰太尔恶性疟原虫分离株中与磺胺多辛-乙胺嘧啶及氯胍耐药性相关的突变
Antimicrob Agents Chemother. 2005 Sep;49(9):3919-21. doi: 10.1128/AAC.49.9.3919-3921.2005.